Teachers Advisors’s Actinium Pharmaceuticals ATNM Stock Holding History

Teachers Advisors’s Portfolio ATNM Stock Details ATNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-1,485	Closed	-$110K	–	3087
2015 Q1	$110K	Buy	1,485 +556	+60%	+$66.1K	﹤0.01%	3007
2014 Q4	$164K	Hold	929	–	–	﹤0.01%	2969
2014 Q3	$187K	Hold	929	–	–	﹤0.01%	2916
2014 Q2	$201K	Buy	+929	New	+$309K	﹤0.01%	2927

Other funds holding ATNM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Teachers Advisors's ATNM Position: Q2 2015 in Review

Teachers Advisors sold out of Actinium Pharmaceuticals (ATNM) in Q2 2015, closing a stake of 1,485 shares — an estimated $110K sold.

Teachers Advisors first reported a position in ATNM in Q2 2014 and held it in 4 quarters. The position peaked at $201K in Q2 2014. 39 funds tracked by Wall St. Rank hold ATNM as of Q2 2015.

Teachers Advisors reported no remaining Actinium Pharmaceuticals position as of Q2 2015 after selling out during the quarter.
Teachers Advisors sold 1,485 Actinium Pharmaceuticals shares in Q2 2015, an estimated $110K.
Teachers Advisors first reported a position in Actinium Pharmaceuticals in Q2 2014 and held it in 4 quarters.
Teachers Advisors's Actinium Pharmaceuticals position peaked at $201K in Q2 2014.
39 funds tracked by Wall St. Rank held Actinium Pharmaceuticals as of Q2 2015.

Based on Teachers Advisors's 13F filing for Q2 2015, filed 10 Aug 2015.